Clinical and Pathogenetic Aspects on Chronic Active Hepatitis

References

• Aldershvile, J., Dietrichson, O., Hardt, F., Nielsen, J.O., Skinhöj, P. Humoral and cell-mediated immunity to hepatitis B virus antigens in acute and chronic liver disease. Scand. J. Gastroent. 12:917–922, 1977
   PubMed Web of Science ®Google Scholar
• Alter, H.J., Purcell, R.H., Holland, P.V., Popper, H. Transmissable agent in non-A, non-B hepatitis. Lancet 1:459–463, 1978
   PubMed Web of Science ®Google Scholar
• Beam, A.G., Kunkel, H.G., Slater, R.J. The problem of chronic liver disease in young women. Amer. J. Med. 21:3–15, 1956
   PubMedGoogle Scholar
• Becker, M.D., Scheuer, P.J., Baptista, A., Sherlock, S. Prognosis of chronic persistent hepatitis. Lancet 1:53–57, 1970
   PubMed Web of Science ®Google Scholar
• Berg, N.O., Eriksson, S. Liver disease in adults with alfa-1-antitrypsin deficiency. N. Eng. J. Med. 287:1264–1276, 1972
   PubMed Web of Science ®Google Scholar
• Bertrams, J., Reis, H.E., Kuwert, E., Selmair, H. Hepatitis associated antigen, HLA-antigens and auto-lymphocytotoxins in chronic aggressive and chronic persistent hepatitis. Z. Immunitaetsforsch. 146:300–307, 1974
   Google Scholar
• Bhagwat, A.G., Warren, K.E. Hepatic reaction to nitrofurantoin. Lancet 2:1369, 1969
   PubMedGoogle Scholar
• Bianchi, L., De Groote, J., Desmet, V.J., Gedigk, P., Korb, G., Popper, H., Paulsen, H., Scheuer, P.J., Schmid, M., Thaler, H., Wepler, W. Morphological criteria in viral hepatitis: Review by an international group. Lancet 1:333–337, 1971
   PubMed Web of Science ®Google Scholar
• Bjørneboe, M. In Hepatitis frontiers, ed. Hartman, F.W., LoGrippo, G.A., Mateer, J.G., Barron, J. pp 563–569, Boston, Toronto, Little Brown, 1956
   Google Scholar
• Bjørneboe, M. Anti-salmonella agglutinins in chronic active liver disease. Lancet 2:484–485, 1971
   PubMedGoogle Scholar
• Bories, P., Coursaget, P., Goudeau, A., Degott, C., Maupas, P., Benhamou, J.P. Antibodies to hepatitis B core antigen in chronic active hepatitis. Br. Med. J. 1:396–397, 1978
   PubMedGoogle Scholar
• Bothwell, P.W., Martin, D., Macara, A.W., Skone, J.F., Wofinden R.C. Infectious hepatitis in Bristol 1959 – 1962. Brit. Med. J. 2:1613–1616, 1963
   PubMedGoogle Scholar
• Bulkley, B.H., Heizer, W.D., Goldfinger, S.E., Isselbacher, K.J. Distinctions in chronic active hepatitis based on circulating hepatitis-associated antigen. Lancet 2:1323–1326, 1970
   PubMed Web of Science ®Google Scholar
• Cochrane, A.M.G., Moussouros, A., Thomson, A.D., Eddleston, A.L.W.F., Williams, R. Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis. Lancet 1:441–444, 1976
   PubMed Web of Science ®Google Scholar
• Cook, G.C., Mulligan, R., Sherlock, S. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q. J. Med. 40:159–185, 1971
   PubMedGoogle Scholar
• Cuny, G., Penin, F. Les hepatites médicamenteuses. J. Sci. Med. Lille 88:467–476, 1970
   Google Scholar
• De Groote, J., Desmet, V.J., Gedigk, P., Popper, H., Poulsen, H., Scheuer, P.J., Schmid, M., Thaler, H., Uehlinger, E., Wepler, W. A classification of chronic hepatitis. Lancet 2:626–628, 1968
   PubMed Web of Science ®Google Scholar
• Dienstag, J.L., Alaama, A., Mosley, J.W., Redeker, A.G., Purcell, R.H. Etiology of sporadic hepatitis B surface antigen-negative hepatitis. Ann. Intern. Med. 87:1–6, 1977
   PubMed Web of Science ®Google Scholar
• Dietrichson, O., Nielsen, J.O., Elling, P., Christoffersen, P. The relevance of a serological classification of chronic hepatitis. Acta pathol. microbiol. Scand. (B) 81:519–524, 1973
   Google Scholar
• Dietrichson, O., Juhl, E., Nielsen, J.O., Oxlund, J.J., Christoffersen, P. The incidence of oxyphenisatin-induced liver damage in chronic non-alcoholic liver disease. Scand. J. Gastroent. 9:473–478, 1974
   PubMed Web of Science ®Google Scholar
• Dietrichson, O. Chronic active hepatitis. Aetiological considerations based on clinical and serological studies. Scand. J. Gastroent. 10:617–624, 1975
   PubMed Web of Science ®Google Scholar
• Dietrichson, O., Christoffersen, P. The prognosis of chronic aggressive hepatitis. A clinical and morphological follow-up study. Scand. J. Gastroent. 12:289–295, 1977
   PubMed Web of Science ®Google Scholar
• Dudley, F.J., Fox, R.A., Sherlock, S. Cellular immunity and hepatitis-associated Australia antigen liver disease. Lancet 1:723–726, 1972
   PubMed Web of Science ®Google Scholar
• Eddleston, A.L.W.F., Williams, R. Inadequate antibody response to HBsAg or suppressor T-cell defect in development of active chronic hepatitis. Lancet 2:1543–1545, 1974
   PubMed Web of Science ®Google Scholar
• Fagrell, B., Strandberg, I., Wengle, B. A nitrofurantoin-induced disorder simulating chronic active hepatitis. Acta Med. Scand. 199:237–239, 1976
   PubMedGoogle Scholar
• Feinstone, S.M., Kapikian, A.Z., Purcell, R.H., Alter, H.J., Holland, P.V. Transfusion-associated hepatitis not due to viral hepatitis A or B. N. Eng. J. Med. 292:767–770, 1975
   PubMed Web of Science ®Google Scholar
• Freudenberg, J., Baumann, H., Arnold, W., Berger, J., Meyer zum Büschenfelde K - H. HLA in different forms of chronic active hepatitis. A comparison between adult patients and children. Digestion 15:260–270, 1977
   Google Scholar
• Frösner, G.G., Overby, L.R., Flehmig, B., Gerth, H.J., Haas, H., Decker, R.H., Ling, C.M., Zuckerman, A.J., Frösner, H.R. Seroepidemiological investigation of patients and family contacts in an epidemic of hepatitis A. J. Med. Virol. 1:163–173, 1977
   PubMedGoogle Scholar
• Gajdusek, D.G. An ‘autoimmune’ reaction against human tissue antigens in certain acute and chronic diseases. 1. Serological investigations. Arch. Intern. Med. 101:9–29, 1958
   Google Scholar
• Galbraith, R.M., Eddleston, A.L.W.F., Smith, M.G.M., Williams, R., Mc Sween, R.N.M., Watkinson, G., Heather, D., Kennedy, L.A., Batchelor, J.R. Histocompatibility antigens in active chronic hepatitis and primary biliary cirrhosis. Br. Med. J. 3:604–605, 1974
   PubMedGoogle Scholar
• Galbraith, R.M., Smith, M., Mackenzie, R.M., Dudley, E., Doniach, E., Williams, R. High prevalence of seroimmunologic abnormalities in relatives of patients with active chronic hepatitis or primary biliary cirrhosis. N. Engl. J. Med. 290:63–69, 1974
   PubMed Web of Science ®Google Scholar
• Galbraith, R.M., Eddleston, A.L.W.F., Williams, R., Webster, A.D.B., Pattison, J., Doniach, D., Kennedy, L.A., Batchelor, J.R. Enhanced antibody responses in active chronic hepatitis: Relation to HLA-B8 and HLA-B12 and portosystemic shunting. Lancet 1:930–934, 1976
   PubMed Web of Science ®Google Scholar
• Good, R.A. Plasma cell hepatitis and extreme hypergammaglobulinemia in adolescent females. Amer. J. Dis. Child. 92:508–509, 1956
   Google Scholar
• Grillner, L., Blomberg, J. Hemolysis-in-gel- and neutralization tests for determination of antibodies to mumps virus. J. clin. Microbiol. 4:11–15, 1976
   Google Scholar
• Hansson, B.G., Johnsson, T. Improved technique for detecting Australia antigen by immunoelectroosmophoresis. Vox. Sang. 21:531–539, 1971
   PubMed Web of Science ®Google Scholar
• Hillis, W.D., Hillis, A., Bias, W.B., Walker, W.G. Associations of hepatitis B surface antigenemia with HLA locus B specificities. N. Eng. J. Med. 296:1310–1314, 1977
   Google Scholar
• Holborow, E.J., Asherson, G.L., Johnson, G.D., Barnes, R.D.S., Carmichael, D.S. Antinuclear factor and other antibodies in blood and liver diseases. Br. Med. J. 1:656–658, 1963
   Google Scholar
• Hollinger, F.B., Sharp, J.T., Lidsky, M.D., Rawls, W.E. Antibodies to viral antigens in systemic lupus erythematosus. Arthritis Rheum. 14:1–11, 1971
   PubMed Web of Science ®Google Scholar
• Hoofnagle, J.H., Gerety, R.J., Tabor, E., Feinstone, S.M., Barker, L.F., Purcell, R.H. Transmission of non-A, non-B hepatitis. Ann. Intern. Med. 87:14–20, 1977
   PubMed Web of Science ®Google Scholar
• Hopf, U., Meyer zum Büschenfelde, K.-H., Arnold, W. Detection of a liver membrane autoantibody in HBsAg-negative chronic active hepatitis. N. Engl. J. Med. 294:578–582, 1976
   PubMed Web of Science ®Google Scholar
• Israel, H.L., Diamond, P. Recurrent pulmonary infiltration and pleural effusion due to nitrofurantoin sensitivity. N. Eng. J. Med. 266:1024–1026, 1962
   Web of Science ®Google Scholar
• Iwarson, S., Lundin, P., Holmgren, J., Hermodsson, S. Multiple attacks of hepatitis in drug addicts: Biochemical, immunochemical and morphologic characteristics. J. Infect. Dis. 127:544–550, 1973
   PubMed Web of Science ®Google Scholar
• Jori, G.P., Peschle, C. Hydralazine disease associated with transcent granulomas of the liver. Gastroenterology 64:1163–1167, 1973
   PubMed Web of Science ®Google Scholar
• Joske, R.A., King, W.E. The LE-cell phenomenon in active chronic viral hepatitis. Lancet 2:477–479, 1955
   Web of Science ®Google Scholar
• Kawanishi, H. In vitro studies on IgG-mediated lymphocyte cytotoxicity in chronic active liver disease. Gastroenterology 73:549–555, 1977
   PubMed Web of Science ®Google Scholar
• Kissmeyer-Nielsen, F., Kjerbye, K.E. in Histocompatibility Testing (editied by Curtoni, E.S., Mattiuz, P.L. and Tosi, R.M.). p 381, Munksgaard, Copenhagen, 1967
   Google Scholar
• Knodell, R.G., Conrad, M.E., Ishak, K.G. Development of chronic liver disease after acute non-A, non-B post transfusion hepatitis. Gastroenterology 72:902–909, 1977
   PubMed Web of Science ®Google Scholar
• Krarup, N.B., Roholm, K. The development of cirrhosis of the liver after acute hepatitis, elucidated by aspiration biopsy. Acta Med. Scand. 108:306–331, 1941
   Google Scholar
• Laitinen, O., Vaheri, A. Very high measles and rubella virus antibody titres associated with hepatitis, systemic lupus erythematosus and infectious mononucleosis. Lancet 1:194–197, 1974
   PubMed Web of Science ®Google Scholar
• Lamberger, B., von Schenck, H. Nitrofurantoininducerad icterus. Läkartidningen 70:2655, 1973
   PubMedGoogle Scholar
• Lee, W.M., Reed, W.D., Mitchell, C.G., Galbraith, R.M., Eddleston, A.L.W.F., Zuckerman, A.J., Williams, R. Cellular and Humoral Immunity to hepatitis B surface antigen in active chronic hepatitis. Br. Med. J. 1:705–708, 1975
   PubMed Web of Science ®Google Scholar
• Lidman, K., Biberfeld, G., Sterner, G., Norberg, R. Chronic active hepatitis in children: A clinical and immunological long term study. Acta Paediat. Scand. 66:73–79, 1977
   PubMed Web of Science ®Google Scholar
• Lundvall, O., Iwarson, S. Experiences with two simple aspiration liver biopsy techniques. Acta Med. Scand. 187:225–228, 1970
   PubMedGoogle Scholar
• Mackay, I.R., Taft, L.I., Cowling, D.C. Lupoid hepatitis. Lancet 2:1323–1326, 1956
   Google Scholar
• Mackay, I.R., Morris, P.L. Association of autoimmune active chronic hepatitis with HL-A 1,8. Lancet 2:793–795, 1972
   PubMed Web of Science ®Google Scholar
• Maddrey, W.C., Boitnott, J.K. Isoniazid Hepatitis. Ann. Intern. Med. 79:1–12, 1973
   PubMed Web of Science ®Google Scholar
• Magnius, L.O., Lindholm, A., Lundin, P., Iwarson, S. A new antigen-antibody system. Clinical significans in long term carriers of hepatitis B surface antigen. JAMA 231:356–359, 1975
   PubMed Web of Science ®Google Scholar
• Mancini, G., Carbonara, A.O., Heremans, J.F. Immunochemical quantitation of antigen by single radial immunodiffusion. Immunochemistry 2:235–254, 1965
   PubMedGoogle Scholar
• Mathews, J.B., Mackay, I.R. Australia antigen in chronic hepatitis in Australia. Br. Med. J. 1:259–261, 1970
   PubMedGoogle Scholar
• Mistilis, S.P., Blackburn, C.R.B. Active chronic hepatitis. Am. J. Med. 48:484–495, 1970
   PubMed Web of Science ®Google Scholar
• Mosley, J.W., Redeker, A.G., Feinstone, S.M., Purcell, R.H. Multiple hepatitis viruses in multiple attacks of acute viral hepatitis. N. Engl. J. Med. 296:75–78, 1977
   PubMed Web of Science ®Google Scholar
• Murray-Lyon, I.M., Stern, R.B., Williams, R. Controlled trial of prednisone and azathioprine in active chronic hepatitis. Lancet 1:735–737, 1973
   PubMed Web of Science ®Google Scholar
• Nielsen, J.O., Dietrichson, O., Elling, P., Christoffersen, P. Incidence and meaning of persistence of Australia antigen in patients with acute viral hepatitis: Development of chronic hepatitis. N. Engl. J. Med. 285:1157–1160, 1971
   PubMed Web of Science ®Google Scholar
• Norkrans, G., Hermodsson, S., Lundin, P., Iwarson, S. The long term outcome of hepatitis B. Infection 4:70–72, 1976
   PubMedGoogle Scholar
• Opelz, G., Vogten, A.J.M., Summerskill, W.H.J., Schalm, S.W., Terasaki, P.I. HLA determinants in chronic active liver disease: Possible relation of HLA-Dw3 to prognosis. Tissue Antigens 9:36–40, 1977
   PubMedGoogle Scholar
• Page, A.R., Sharp, H.L., Greenberg, L.J., Yunis, E.J. Genetic analysis of patients with chronic active hepatitis. J. Clin. Invest. 56:530–535, 1975
   Google Scholar
• Read, A.E., Sherlock, S., Harrison, C.V. Active “juvenile” cirrhosis considered as a part of a systemic disease and the effects of corticosteroid therapy. Gut 4:378–393, 1963
   PubMed Web of Science ®Google Scholar
• Reynolds, T.B. Recurring jaundice associated with ingestion of a laxative “Dialose Plus”. Gastroenterology 56:418, 1969
   Web of Science ®Google Scholar
• Reynolds, T.B., Peters, R.L., Yamada, S. Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin. N. Engl. J. Med. 285:813–820, 1971
   PubMed Web of Science ®Google Scholar
• Rosenow, E., De Remee, E., Dines, D. Chronic nitrofurantoin pulmonary reaction. N. Engl. J. Med. 279:1258–1262, 1968
   PubMed Web of Science ®Google Scholar
• Saint, E.G., King, W.E., Joske, R.A., Finck, E.S. The course of infectious hepatitis with special reference to prognosis and the chronic stage. Australas Ann. Med. 2:113–127, 1953
   PubMedGoogle Scholar
• Schalm, S.W., Summerskill, W.H.J., Gitnick, G.L., Elveback, L.R. Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigen. Gut 17:781–786, 1976
   PubMed Web of Science ®Google Scholar
• Schweitzer, I.L., Peters, R.L. Acute submassive hepatic necrosis due to methyldopa. A case demonstrating possible initiation of chronic liver disease. Gastroenterology 66:1203–1211, 1974
   PubMed Web of Science ®Google Scholar
• Scott, B.B., Rajah, S.M., Losowsky, M.S. Histocompatibility antigens in chronic liver disease. Gastroenterology 72:122–125, 1977
   PubMedGoogle Scholar
• Selmair, H., Vido, I., Kaboth, U., Schober, A. Australia SH-antigen Befundet bei floriden und ausgeheilten chronisch-persistierenden hepatitiden. Dtsch. med. Wschr. 96:1908–1911, 1971
   PubMed Web of Science ®Google Scholar
• Sever, J.L. Application of a microtechnique on viral serological investigations. J. Immunol. 88:320–329, 1962
   PubMed Web of Science ®Google Scholar
• Soloway, R.D., Summerskill, W.H.J., Baggenstoss, A.H., Geall, M.G., Gitnick, G.L., Elveback, L.R., Schoenfield, L.J. Clinical, biochemical and histological remission in severe chronic active liver disease: A controlled study of treatment and early prognosis. Gastroenterology 63:820–833, 1972
   PubMed Web of Science ®Google Scholar
• Sternlieb, I., Scheinberg, I.H. Chronic hepatitis as a first manifestation of Wilsons disease. Ann. Intern. Med. 76:59–64, 1972
   PubMed Web of Science ®Google Scholar
• Tage-Jensen, U., Arnold, W., Dietrichson, O., Hardt, F., Hopf, U., Meyer zum Buschenfelde, K.-H., Nielsen, J.O. Liver-cell-membrane autoantibody specific for inflammatory liver diseases. Br. Med. J. 1:206–208, 1977
   PubMedGoogle Scholar
• Thomas, E., Rosenthal, W.R., Zapiak, L., Micci, D. Spectrum of methyldopa liver injury. Am. J. Gastroenterol. 68:125–133, 1977
   PubMedGoogle Scholar
• Tisdale, W.A. Focal hepatitis, fever and skin rash following therapy with sulfamethoxypyridazine, a long-acting sulphonamide. N. Engl. J. Med. 258:687–690, 1958
   PubMed Web of Science ®Google Scholar
• Triger, D.R., Alp, M.H., Wright, R. Bacterial and dietary antibodies in liver disease. Lancet 1:60–63, 1972
   PubMed Web of Science ®Google Scholar
• Tönder, M., Nordöy, A., Elgjo, K. Sulfonamide-induced liver disease. Scand. J. Gastroent. 9:93–96, 1974
   PubMed Web of Science ®Google Scholar
• Waldenström, J. Leber, Blutproteine und Nahrungseiweiss. Stoffwechsel Krh. Sonderband XV, p. 113–119, Bad Kissingen Tagung Verlag, 1950
   Google Scholar
• Wright, R., Mc Collum, R.W., Klatskin, G. Australia antigen in acute and chronic liver disease. Lancet 2:117–121, 1969
   PubMed Web of Science ®Google Scholar
• Wright, R. Australia antigen and smoothe-muscle antibody in acute and chronic hepatitis. Lancet 1:521–522, 1970
   PubMed Web of Science ®Google Scholar